J&J Sees Continued Use of DTC Ads For High-End Devices
This article was originally published in The Gray Sheet
Executive Summary
Direct-to-consumer advertising for Class III devices has become increasingly popular with industry, Johnson & Johnson Senior Counsel Marlene Tandy, MD/JD, said at a recent Indiana Medical Device Manufacturers Council meeting
You may also be interested in...
Stryker Discusses Gainsharing, Looks To Diversified Product Line For Growth
Stryker has doubts that gainsharing efforts being considered by hospitals as a way to mediate rampant price increases for certain orthopedic and cardiac devices would be well received by physicians
Stryker Discusses Gainsharing, Looks To Diversified Product Line For Growth
Stryker has doubts that gainsharing efforts being considered by hospitals as a way to mediate rampant price increases for certain orthopedic and cardiac devices would be well received by physicians
Stryker Ceramic Hip, DTC Advertising Aids Q1 23% Orthopedic Implant Growth
Stryker credits Trident ceramic-on-ceramic hip sales and direct-to-consumer advertising featuring pro golfer Jack Nicklaus with driving its 24% U.S. hip revenue growth during the first quarter